Cuando:
23 diciembre, 2016 – 28 marzo, 2017 todo el día Europe/Madrid Zona Horaria
2016-12-23T00:00:00+01:00
2017-03-29T00:00:00+02:00

Las iniciativas deben implicar a un amplio rango de partners, incluyendo empresas de mediano tamaño, de diferentes sectores. Implicar a la mayor población posible, en este sentido tiene que ayudar a desarrollar nuevos acercamientos y tecnologías para la prevención, diagnóstico y tratamiento de enfermedades con gran impacto en la salud pública.

Temática:

  • Topic 1: Understanding hypoglycaemia: the underlying mechanisms and addressing clinical determinants as well as consequences for people with diabetes by combining databases from clinical trials.
  • Topic 2: How big data could support better diagnosis and treatment outcomes for prostate cancer (part of the Big Data for Better Outcomes programme).
  • Topic 3: Improving the care of patients suffering from acute or chronic pain (this topic includes three subtopics on patient reported outcomes; biomarkers; and chronic pelvic pain).
  • Topic 4: Creation of a pan-European paediatric clinical trials network.
  • Topic 5: Biomanufacturing 2020: development of innovative high throughput analytical tools and methods to characterize cell culture fluid during development and commercial cell culture processes.
  • Topic 6: Unlocking the solute carrier gene-family for effective new therapies (unlock SLCs).
  • Topic 7: Patient perspectives in medicines lifecycle.
  • Topic 8: Personalised medicine approaches in autism spectrum disorders.

Bases